LEADER 04374nam 2201201z- 450 001 9910585940303321 005 20231214133635.0 035 $a(CKB)5600000000483079 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/91188 035 $a(EXLCZ)995600000000483079 100 $a20202208d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNew Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (232 p.) 311 $a3-0365-4736-3 311 $a3-0365-4735-5 330 $aNew approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganisms, which constitute a major challenge to global health. The antibiotic crisis is now a general concern; therefore, alternative biomolecules or drug delivery systems to treat infections are urgently needed. From natural extracts to traditional medicine remedies, to newly engineered nanocapsules and nanoparticles, to bio-based, biodegradable delivery platforms, many systems to fight infections are explored in this book. 606 $aResearch & information: general$2bicssc 606 $aChemistry$2bicssc 610 $ananoparticles 610 $a4-Nerolidylcatechol 610 $aantifungals 610 $aMicrosporum canis 610 $apolycaprolactone 610 $ananoprecipitation 610 $asilver nanoparticles 610 $agreen synthesis method 610 $aCatharanthus roseus 610 $aAzadirachta indica 610 $amultidrug-resistant bacteria 610 $awound healing 610 $anosocomial infection 610 $aplant extract 610 $agrapefruit seed extract 610 $aantibacterial activity 610 $afiber-hydrogel composite 610 $abiodegradable polymers 610 $askin regeneration 610 $adrug delivery platforms 610 $acontrolled release 610 $atetramycin 610 $aantimicrobial activity 610 $akiwifruit disease 610 $aconventional antibiotics 610 $astorage quality 610 $agold nanoparticles 610 $aflavonoids 610 $aGram-negative bacteria 610 $aDNA gyrase 610 $ain silico 610 $amultidrug-resistant Acinetobacter baumannii (MDR-AB) 610 $ahypertonic saline 610 $aantibiotics 610 $abiofilm 610 $aaerosol delivery 610 $aultrahigh-throughput screening 610 $alive biosensors 610 $aantibiotic discovery 610 $agram-negative pathogens 610 $amicrofluidic droplet cocultivation 610 $aefficient promoters 610 $apolymyxins 610 $acolistin biosynthetic gene cluster 610 $asingle cell 610 $amulti-omics 610 $aquercetin 610 $amagnesium-doped calcium silicate 610 $aosteogenic activity 610 $abone regeneration and nanofiber scaffold 610 $abulk-tank milk 610 $amastitis 610 $amethicillin 610 $amilk 610 $agoat 610 $asomatic cell counts 610 $astaphylococcus 610 $atetracycline 610 $atotal bacterial counts 610 $aprosthetic joint infection 610 $alocal prevention 610 $aallicin 610 $achitosan 610 $aSphaerotheca sp. 610 $aantibiotic 610 $aRosa roxburghii 610 $acyclic diphenylphosphonate 610 $aquinoline 610 $aDNA gyrase inhibitor 610 $amolecular docking 610 $amagnesium ion 615 7$aResearch & information: general 615 7$aChemistry 700 $aFelgueiras$b Helena$4edt$01315229 702 $aFelgueiras$b Helena$4oth 906 $aBOOK 912 $a9910585940303321 996 $aNew Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics$93032276 997 $aUNINA